GENE ONLINE|News &
Opinion
Blog

2023-02-01| Special

Biotech Showcase 2023: Digital Medicine Innovation: Its Time is Now

by Justine Zhu
Share To
Over the past three years, the importance and potential of digital healthcare technology have been brought to the forefront. What do investors seek in the next generation of digital healthcare products? In the 2023 Biotech Showcase, the panel, Digital Medicine Innovation: Its Time is Now, examines the current funding trends, showcases the stakeholders' knowledge in evaluating the value of digital therapeutics in healthcare, and delves into where investors are putting their focus. Three professionals broke away from the framework starting from a medical perspective and changed to a consumer and digital product developer perspective to find product positioning and implementation methods.

It's free! Log in now to read

LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top